Evexithroid Tablet
Product Images NDC 73352-697

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Evexithroid (NDC 73352-697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label120b (120mg)

This text provides information about EvexiTHROID Thyroid Tablets containing Levothyroxine and Liothyronine. It includes guidance on storage conditions between 15°C to 30°C, warning about the distinct odor from thyraid extract, and a caution to keep the tablets out of reach of children. The tablets are distributed by a company based in San Antonio, TX, with an expiration date of February 6, 2025.*

FDA Label Image

Label15 (15mg)

Each tablet contains a combination of Levothyroxine and Liothyronine in specified quantities. The medication, EvexiTHROID, comes in a pack of 100 tablets with specific dosage instructions. It is important to store the tablets in a tight container protecting them from light and moisture. The product contains a thyraid extract that may have a unique odor. The tablets should be stored at temperatures between 15°C and 30°C and kept out of the reach of children. The product is distributed by Trifluent Pharmaceuticals with an expiration date in February 2025.*

FDA Label Image

Label180a (180mg)

This text provides information about EvexiThroid thyroid tablets, each containing Levothyroxine and Liothyronine. The directions for use recommend once daily intake of 15mg to 180mg. It highlights the presence of thyroid extract with a strong odor and instructs proper storage conditions. Distributed by Trifluent Pharma, LLC, the tablets are indicated for prescription use. The NDC code and GTIN are also provided for identification.*

FDA Label Image

Label30a (30mg)

This text describes a medication in tablet form called Lovothyroxine, with each tablet containing 15 mg - 180 mg to be taken once a day. The medication comes in a pack of 100 tablets with NDC 73352-694-10. It is advised to store the tablets in a tight container protected from light and moisture, between 15°C and 30°C (59°F and 86°F), and out of reach of children. The tablets may have a strong odor due to thyraid extract. This medication is distributed by Trifluent Pharma, LLC in San Antonio, TX, with an expiration date of February 6, 2025.*

FDA Label Image

Label45a (45mg)

This is a description of a medication called EvexiTHROID, which is a combination of Levothyroxine and Liothyronine. Each tablet contains 285 micrograms of Levothyroxine and 75 micrograms of Liothyronine. The medication is used for thyroid-related issues. It is recommended to store the tablets in a tight container protected from light and moisture between 15°C and 30°C. A child-resistant closure is provided, and the medication should be kept out of the reach of children. This medication is available in a pack of 100 tablets and is distributed by Trifluent Pharma, LLC. The expiration date is February 2025.*

FDA Label Image

Label60a (60mg)

This text provides information about Evexi THROID Thyroid Tablets, which contain Levothyroxine and Liothyronine. The directions for use are not clearly visible, but it mentions a dosage of 15 mg - 180 mg once a day. The tablets contain thyroid extract that may have a strong odor. Storage instructions include keeping the tablets in a tight container protected from light and moisture, between 15°C and 30°C (59°F and 86°F), and out of reach of children. The tablets are distributed by Trifluent Pharma, LLC in San Antonio, TX, with an expiration date of February 6, 2025. The NDC number is 73352-686-10.*

FDA Label Image

Label75a (75mg)

This text contains information about a medication called EvexiTHROID which includes Levothyroxine and Liothyronine. The directions for use suggest taking 15 mg - 180 mg once a day. It also mentions to store the tablets in a tight container protected from light and moisture at a temperature between 15°C and 30°C. The medication may have a strong odor due to the thyroid extract. This product is distributed by Trifluent Pharma, LLC and is for prescription use only with a count of 100 tablets in a package. It is advised to keep it out of the reach of children.*

FDA Label Image

Label90a (90mg)

This is a description for a medication called Evexi THROID, containing Thyroid Tablets, USP with a dosage of 15mg - 180 mg once a day. The tablets contain thyraid extract and may have a strong odor. The medication should be stored in a tightly closed container protected from light and moisture, with a child-resistant closure. It should be stored between 15°C and 30°C (59°F and 86°F) and kept out of the reach of children. The medication is distributed by Triluert Pharma, LLC based in San Antonio, TX.*

FDA Label Image

Table (Table 2)

This is a list of different strengths of medication in grain sizes, with corresponding amounts of T3 and T4 hormones. Each bottle contains 100 tablets and is identified by a unique NDC code. The range includes strengths from 15 mg to 180 mg, catering to different dosages of T3 and T4 hormones.*

FDA Label Image

Liothyronine (Renthyroid 01)

FDA Label Image

Levothyroxine (Renthyroid 02)

Levothyroxine (T4)*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.